Summary.-Nineteen cases of malignant lymphomata were selected for study from a group of about 1500 collected cases of malignant lymphomata because they showed histological evidence of non-infectious epithelioid-cell granulomata in one or more tissues.
In the 19 cases selected, 5 cases of systemic sarcoidosis, 4 cases of an associated malignancy, 1 pre-malignant condition, and 1 case of an auto-immune disease were found.
This remarkable association of sarcoid reactions or sarcoidosis with malignant lymphomata and associated malignancies seems to justify speculation on the possibility of a common aetiological factor, e.g. in the form of an altered immune reaction.
FOR many years it has been known that in patients with Hodgkin's disease non-caseating epithelioid-cell granulomata (NCECG) may occur without any demonstrable infectious or other exogenous genesis (Bonenfent, 1954; Jackson and Parker, 1947; Kadin et al., 1970; Nickerson, 1937; Pettet et al., 1955; Rappaport, 1966) . In such patients these granulomata may be found both in tissues directly involved by Hodgkin's disease as well as in uninvolved tissues; and as a rule no clinical evidence of svstemic sarcoidosis is present (Goldfarb and Cohen, 1970; Hastings and Thompson, 1949; Herbeuval et al., 1960; Kadin et al., 1970; Wurm et al., 1958) . In a small number of cases, however, coexistence of " true " systemic sarcoidosis and Hodgkin's disease, has been reported, and in all these cases sarcoidosis was diagnosed first (Goldfarb and Cohen, 1970; Herbeuval et al., 1960; Lamache et al., 1954; Pautrier, 1] 934). NCECG with (Atwood et al., 1966;  Buckle, 1960; Raben et al., 1961; Silver et al., 1967) or without (Kissel et al., 1962) clinical evidence of systemic sarcoidosis have also been reported in patients with other malignant lymphomata, though less frequently, and again in these cases wit,h coexistence of sarcoidosis and malignant lymphoma the former disease has been diagnosed first.
The significance of NCECG in some patients with malignant lymphoma is still obscure and the frequency of this finding in different kinds of lymphomata is not well known. In a recent series, however, NCECG were found in 31 of 185 patients with Hodgkin's disease (Kadin et al., 1970) . In the cases where NCECG have been observed exclusively in the tissues invaded by Hodgkin's disease, this finding has been thought to represent an especially hiighly differentiated variety of the histiocytic epithelioid-cell proliferation commonly occurring in Hodgkin's disease (Bonenfent, 1954; Herbeuval et at., 1960; Pautrier, 1934) . The demonstration of NCECG in uninvolved organs in patients with malignant lymphomata has generated speculation on a possible underlying immunological mechanism (Atwood et al., 1966; Brincker, 1970; Kadin et al., 1970) or has been interpreted as sarcoid reactions (Kadin et al., 1970; Kissel et al., 1962) analogous to the sarcoid reactions occasionally seen in lymph-nodes draining an area involved with carcinoma (Gorton and Linell, 1957; Nadel and Ackerman, 1950; Nickerson, 1937; Symmers, 1951) . Finally coexistence of systemic sarcoidosis and malignant lymphoma has been considered accidental (Goldfarb and Cohen, 1970; Silver et al., 1967) or as an example of malignant transformation of sarcoidosis (Lamache et al., 1954; Raben et al., 1961) .
With one exception (Kadin et al., 1970) (cases 5, 9, 13, 14, 15 and 17) have been described in detail in an earlier report (Brincker, 1970) . The finding of 13 additional cases and the appearance of more recent literature has provided material for a re-evaluation and discussion of the subject. Table I shows the pertinent data for 14 patients with malignant lymphomata and NCECG, but without clinical evidence of sarcoidosis, while Table II shows similar data for 5 patients with malignant lymphomata (including chronic lymphatic leucaemia) and clinical as well as histological evidence of sarcoidosis.
NCECG occurred with all types of malignant lymphomata but was associated chiefly with Hodgkin's disease (12 of the 19 cases). This agrees well with the impression obtained from reviewing the literature. Case 1 seems to be the first reported example of follicular lymphoma associated with NCECG. In the cases without evidence of sarcoidosis NCECG were found exclusively in the tissues invaded by malignant lymphoma in 7 patients, while NCECG were present in both involved and uninvolved tissues in the remaining 7 cases. In the latter group the mediastinal lymph nodes and the spleen were the most frequent sites.
Four of the 19 patients (cases 6, 14, 15 and 19) had a second malignant disease, and in 3 of these cases the associated malignancy preceded the diagnosis of malignant lymphoma or sarcoidosis. Case 15 even presented a premalignant condition in addition to 2 malignancies and sarcoidosis. In case 13 a diagnosis of rheumatoid arthritis preceded the diagnosis of Hodgkin's disease, but no evidence of auto-immune disease was found in the remnaining 18 patients. (Atwood et al., 1966; Buckle, 1960; Goldfarb and Cohen, 1970; Herbeuval et al., 1960; Lamache et al., 1954; Pautrier, 1934; Raben et al., 1961; Silver, 1967 As an alternative interpretation of cases 15 and 16 it might be suggested that a non-specific sarcoid reaction could give rise to a clinical picture, indistinguishable from that seen in " true " systemic sarcoidosis. However, such an assumption would make it difficult to maintain the' concept of sarcoidosis as an independent disease.
With an annual incidence of sarcoidosis in Denmark of 5 per 100,000 (Horwitz et al., 1967) the finding of 5 patients with sarcoidosis in a series of 1500 patients with malignant lymphomata appears to be well beyond The number that might be expected. This association suggests a connection between sarcoidosis and malignant lymphomata. A connection between sarcoidosis and Hodgkin's disease has repeatedly been suspected on the basis of similar clinical and immunological findings in the two diseases (Jorgensen, 1964) , but no convincing evidence of such a relationship has so far been presented.
In patients receiving intense-immunosuppressive treatment in order to prevent the rejection of transplanted organs, an abnormally high incidence of malignant lymphomata and other malignancies has been noted (Penn, 1970) . Also in certain rare hereditary-diseases associated with immunological deficiency, e.g. ataxiateleangiectasia, Chediak-Higashi syndrome, Wiskott-Aldrich syndrome and agammaglobulinaemia, an abnormally high incidence of malignant lymphomata and possibly of other malignancies has been described (Doll and Kinlen, 1970; Lynch, 1969) . A similar association has been observed in diseases with an altered immune response such as dermatomyositis (Williams, 1959 ), Sj6gren's syndrome (Talal et al., 1967) and systemic lupus erythematosus (Nilsen et al., 1967) . These findings have been considered to support the hypothesis that one aspect of the development of malignancies mnay be related to a breakdown in immunological surveillance (Doll and Kinlen, 1970; Keast, 1970) .
The immunological defect in sarcoidosis involves both cell-mediated immunity and immunoglobulin synthesis (Chase, 1966) . This suggests a relationship with the conditions mentioned above and thus raises the possibility that the immunological defect in sarcoidosis may somehow lead to the development of malignancies, especially malignant lymphomata, through a breakdown in immunological surveillance.
The findings of 4 cases of an associated malignancy in this series of 19 cases deserves special consideration. Information on the frequency of multiple malignancies may be derived partly from autopsy material, partly from cases in which multiple malignancies have been found intra vitam. The reported frequency of multiple malignancies in autopsy material is generally higher for a number of reasons than that reported in living patients (Moertel et al., 1961) . In the latter group one of the highest incidence figures has been reported by these workers, who found 4.6%/ cases with more than one malignancy. Applied to the present series of 19 patients this figure would correspond to an expected number of 0 9 patients having more than one malignancy. In a group of randomly selected individuals with the same age and sex distribution as in the present series, the expected incidence of cancer detected from birth to the end of the observation period would be 1 28 per 19 patients, based on published Danish cancer incidence rates (Clemmesen, 1964) .
Not including the malignant lymphomata, the 4 cases of associated malignancy (plus one premalignant condition) appear to be at least three times the expected number. It is possible, however, that this apparently high incidence is fortuitous.
In 3 of the 4 cases of multiple malignancies the associated malignancy was diagnosed before the malignant lymphoma, and in the 2 cases also associated with sarcoidosis, the associated malignancy was diagnosed before either sarcoidosis The above speculations consider malignant disease to be the result of sarcoidosis, or both malignant disease and sarcoid reactions the result of an underlying altered immune reaction. Previous views, on the contrary, have held that sarcoid reactions are a consequence of malignant disease. Thus, in the latter case, it has been suggested that metabolic products from the tumour somehow give rise to the mainly regional sarcoid reactions (Gorton and Linell, 1957; Symmers, 1951 ). An associated malignancy preceded sarcoidosis or sarcoid reaction in 3 of the 4 cases and the question may be posed in case 14 whether the preceding malignancy could be the cause of the NCECG later demonstrated in the liver, spleen and bone marrow in this patient. However, in cases 15 and 19 with unequivocal clinical evidence of sarcoidosis the NCECG present cannot be considered a mere sarcoid reaction unless the concept of " true " systemic sarcoidosis as a disease sui generis is challenged.
The 3 cases of associated malignancy, preceding malignant lymphomata by 1, 5 and 29 years, respectively, had been cured by radiotherapy. It must be considered, therefore, whether the radiotherapy given could be a possible causative factor in the ensuing development of Hodgkin's disease in cases 14 and 15 and chronic lymphatic leukaemia in case 19. Such an assumption appears reasonable in case 19, the interval between radiotherapy and diagnosis of leukaemia being 29 years. It should be remembered, however, that similar causative factors have also been involved in the cases from which the frequencies of multiple malignancies have been calculated (Moertel et al., 1961) .
In view of the increased incidence of malignant lymphomata in patients with auto-immune disorders (Lynch, 1969; Nilsen et al., 1967; Talal et al., 1967; Williams, 1959) it is of interest that one of the patients (case 13) was treated for rheumatoid arthritis 4 years before Hodgkin's disease was diagnosed. This case was the only example of an auto-immune disease in the series, and the association with Hodgkin's disease may have been quite fortuitous. It should be mentioned, however, that a significantly increased frequency of preceding rheumatic disease has been found in patients with all types of lymphomata (Lea, 1964) .
In 19 cases of malignant lymphomata, selected for study because of the demonstration of NCECG in one or more tissues, it seems remarkable to find 5 cases of systemic sarcoidosis, 4 cases of an associated malignancy, 1 premalignant condition and 1 case of an auto-immune disease. Taken separately each of these manifestations could be considered fortuitous, but viewed together they seem to justify speculation on the possibility of a common etiological factor, e.g. in the form of an altered immune reaction.
